Legal & General Group Plc cut its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 12.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 999,263 shares of the company’s stock after selling 138,227 shares during the quarter. Legal & General Group Plc’s holdings in Avantor were worth $11,452,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Private Trust Co. NA lifted its stake in Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares in the last quarter. Osaic Holdings Inc. lifted its stake in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after buying an additional 1,064 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after buying an additional 1,189 shares in the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in Avantor by 0.6% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 206,386 shares of the company’s stock worth $2,576,000 after purchasing an additional 1,279 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Avantor
In other news, Director Simon Dingemans purchased 25,000 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was acquired at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the acquisition, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Sanjeev K. Mehra purchased 125,000 shares of the business’s stock in a transaction dated Tuesday, March 10th. The shares were purchased at an average price of $8.01 per share, with a total value of $1,001,250.00. Following the acquisition, the director directly owned 475,000 shares in the company, valued at approximately $3,804,750. The trade was a 35.71% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 160,000 shares of company stock worth $1,287,950 in the last 90 days. Insiders own 0.28% of the company’s stock.
Avantor Stock Up 1.3%
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business’s revenue was up .0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.23 EPS. On average, equities research analysts predict that Avantor, Inc. will post 0.79 earnings per share for the current year.
Analysts Set New Price Targets
A number of research analysts have weighed in on the stock. Morgan Stanley set a $10.00 target price on shares of Avantor in a research note on Friday, February 13th. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Citigroup decreased their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. UBS Group reissued a “neutral” rating and issued a $10.50 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, Jefferies Financial Group reissued an “underperform” rating and issued a $8.00 target price on shares of Avantor in a research note on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $10.57.
Read Our Latest Research Report on AVTR
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Read More
- Five stocks we like better than Avantor
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
